In Situ Identification of CD44+/CD24- Cancer Cells in Primary Human Breast Carcinomas

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Perrone, Giuseppe ^a   Gaeta, Laura Maria ^a   Zagami, Mariagiovanna ^a,c   Nasorri, Francesca ^b   Coppola, Roberto ^a   Borzomati, Domenico ^a   Bartolozzi, Francesco ^a   Altomare, Vittorio ^a   Trodella, Lucio ^a   Tonini, Giuseppe ^a   Santini, Daniele ^a   Cavani, Andrea ^b   Muda, Andrea Onetti ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; ESTROGEN RECEPTOR; HERMES ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL SUBPOPULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD24; ANTIGENS, CD44; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; IMMUNOPHENOTYPING; MAMMARY GLANDS, HUMAN; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 84866431362     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043110     Document Type: Article

References (29)

1. Clarke MF, Fuller M, (2006) Stem cells and cancer: two faces of eve. Cell 124: 1111-1115.
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumourigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988.
3. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, et al. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648.
4. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
5. Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, et al. (2008) The CD44+/CD24- phenotype is enriched in basal-like breast tumours. Breast Cancer Res 10: R53.
6. Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, et al. (2005) Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 11: 1154-1159.
7. Dey D, Saxena M, Paranjape AN, Krishnan V, Giraddi R, et al. (2009) Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One 4: e5329.
8. Pandit TS, Kennette W, Mackenzie L, Zhang G, Al-Katib W, et al. (2009) Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment. Int J Oncol 35: 297-308.
9. Phillips TM, McBride WH, Pajonk F, (2006) The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777-1785.
10. Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, et al. (2006) CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8: R59.
11. Fillmore C, Kuperwasser C, (2007) Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man? Breast Cancer Res 9: 303.
12. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, et al. (2008) Intrinsic resistance of tumourigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672-679.
13. Fillmore CM, Kuperwasser C, (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10: R25.
14. Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, et al. (2003) CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 9: 4906-4913.
15. Mylona E, Giannopoulou I, Fasomytakis E, Nomikos A, Magkou C, et al. (2008) The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumour cells in invasive breast carcinomas. Hum Pathol 39: 1096-1102.
16. Ahmed MA, Aleskandarany MA, Rakha EA, Moustafa RZ, Benhasouna A, et al. (2011) A CD44(-)/CD24 (+) phenotype is a poor prognostic marker in early invasive breast cancer. Breast Cancer Res Treat in press.
17. Snyder EL, Bailey D, Shipitsin M, Polyak K, Loda M, (2009) Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumours by quantum dot-conjugated antibodies. Lab Invest 89: 857-866.
18. Hebbard L, Steffen A, Zawadzki V, Fieber C, Howells N, et al. (2000) CD44 expression and regulation during mammary gland development and function. J Cell Sci 113: 2619-2630.
19. Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ, (2006) CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res 8: R7.
20. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, et al. (2008) Brca1 breast tumours contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 10: R10.
21. Fidler IJ, (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
22. Sobin LH, Gospodarowicz M, Wittekind C (2009) TNM Classification of malignant Tumours. UICC International Union Against Cancer, 7th Ed. New York, Chichester, Weinheim, Brisbane, Singapore, Toronto: Wiley-Blackwell.
23. Robins P, Pinder S, de Klerk N, (1995) Histological grading of breast carcinomas: a study of interobserved agreement. Human Pathol 28: 873-879.
24. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, et al. (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295: 2492-2502.
25. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, et al. (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10: 5367-5374.
26. Hyun CL, Lee HE, Kim KS, Kim SW, Kim JH, et al. (2008) The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer. J Clin Pathol 61: 317-321.
27. Gaviraghi M, Tunici P, Valensin S, Rossi M, Giordano C, et al. (2011) Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells. Biosci Rep 31: 45-55.
28. Jijiwa M, Demir H, Gupta S, Leung C, Joshi K, et al. (2011) CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS One 6: e24217.
29. Yang YM, Chang JW, (2008) Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells. Cancer Invest 26: 725-733.